In conclusion, our data show that PLAU is induced in NSCLC cells with ARID1A loss and promotes NSCLC cell growth, survival, and cisplatin resistance through stabilization of TM4SF1. The gene discussed is TM4SF1; the disease is non-small cell lung carcinoma.